T. Pollmacher et al., EFFECTS OF CLOZAPINE ON PLASMA CYTOKINE AND SOLUBLE CYTOKINE RECEPTORLEVELS, Journal of clinical psychopharmacology, 16(5), 1996, pp. 403-409
The antipsychotic drug clozapine frequently induces fever during the f
irst weeks of administration. In addition, it has been shown that cloz
apine increases plasma soluble interleukin-2 receptor (sIL-2r) levels
as early as 1 week after treatment is started. These findings suggest
that clozapine has immunomodulatory effects. To investigate this issue
in more detail, we assessed the time course of rectal temperature, bl
ood cell counts, and cytokine and soluble cytokine receptor plasma lev
els during 6 weeks of clozapine treatment in 27 schizophrenic patients
. Clozapine increased the plasma levels of tumor necrosis factor-alpha
(TNF-alpha), soluble TNF receptors p55 and p75, and sIL-2r. These inc
reases were independent of prior or concurrent medication and did also
occur in patients who did not experience clozapine-induced fever. How
ever, increases in TNF-alpha and sIL-2r levels were more pronounced in
patients with clozapine-induced fever who showed in addition increase
d plasma IL-6 levels and granulocyte counts. Plasma IL-1 receptor anta
gonist levels and monocyte and lymphocyte counts were not affected by
clozapine treatment. It is concluded that clozapine has consistent in
vivo immunomodulatory effects. The results presented suggest that cloz
apine-induced fever is mediated by pyrogenic cytokines.